Comparison of efficacy between canagliflozin and teneligliptin as add-on therapy to metformin and glimepiride on plasma glucose levels along with blood pressure and lipid levels in patients with type 2 diabetes mellitus

Comparison of efficacy between canagliflozin and teneligliptin as add-on therapy to metformin and glimepiride on plasma glucose levels along with blood pressure and lipid levels in patients with type 2 diabetes mellitus

Background: Despite of several guidelines metformin and glimepiride remains the first prescribed drug in most people with diabetes. Very often canagliflozin and teneligliptin remain the third prescribed OHA. Efficacy of teneligliptin and canagliflozin as solo drug or in combination with other single...

Full description

Bibliographic Details
Main Authors: Ashish Gautam, Shoor Vir Singh, Ankit Gupta, Anupam Sharma, Saurabh Gupta, Nikhil Pursnani, Prabhat Agrawal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Diabetology
Subjects:
canagliflozin
high-density lipoprotein cholesterol
hypertension
teneligliptin
third oral hypoglycemic agent
triglycerides
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2023;volume=14;issue=3;spage=157;epage=160;aulast=Gautam

Internet

http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2023;volume=14;issue=3;spage=157;epage=160;aulast=Gautam

Similar Items